ZyVersa Therapeutics, Inc.
ZVSA
$0.7151
$0.00711.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,145.65% | 2.85% | -94.12% | -35.19% | 98.75% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -30.88% | -48.74% | -39.77% | 302.09% | -49.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 339.50% | -39.13% | -77.88% | -13.51% | 67.22% |
|
|
|||||
| Total Current Assets | 339.50% | -39.13% | -77.88% | -13.51% | 67.22% |
| Net Property, Plant & Equipment | -- | -- | -60.47% | -70.95% | -63.55% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | -39.47% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -38.87% | 116.02% | 81.22% | 0.00% | -- |
| Total Assets | 6.05% | -0.23% | -10.07% | -2.10% | -32.69% |
|
|
|||||
| Total Accounts Payable | 0.57% | 11.64% | 2.32% | -3.60% | -5.24% |
| Total Accrued Expenses | -16.15% | 34.65% | 15.43% | 16.07% | -41.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -74.64% |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 0.00% | -98.56% | -20.32% |
| Total Other Current Liabilities | 0.00% | 0.00% | 0.00% | -98.56% | -20.32% |
| Total Current Liabilities | -2.69% | 15.48% | 4.30% | -6.00% | -12.92% |
|
|
|||||
| Total Current Liabilities | -2.69% | 15.48% | 4.30% | -6.00% | -12.92% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.34% | 0.00% | 1.15% | 0.00% | -41.37% |
| Total Liabilities | -2.53% | 14.26% | 4.05% | -5.54% | -16.04% |
|
|
|||||
| Common Stock & APIC | 2.46% | 0.69% | 0.14% | 2.60% | 4.30% |
| Retained Earnings | -1.28% | -2.21% | -2.61% | -2.74% | -14.84% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 21.19% | -18.48% | -23.19% | 1.34% | -43.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.19% | -18.48% | -23.19% | 1.34% | -43.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 21.19% | -18.48% | -23.19% | 1.34% | -43.79% |
|
|
|||||